KalVista Pharmaceuticals' Sebetralstat Poised to Disrupt Acute HAE Market With Oral Advantage, BofA Says

MT NewswiresDec 18 23:54

KalVista Wins New Buy at BofA on Potential of Lead Candidate

Seeking AlphaDec 18 22:52

BioCryst Pharmaceuticals, Inc.'s (NASDAQ:BCRX) Institutional Investors Lost 5.5% Last Week but Have Benefitted From Longer-term Gains

Simply Wall StDec 18 21:40

Bullish BioCryst Pharmaceuticals Insiders Loaded Up On US$1.05m Of Stock

Simply Wall StNov 27 21:35

BioCryst Pharmaceuticals' Hereditary Angioedema Drug Gets Recommendation From Ireland Regulator

MT NewswiresNov 18 16:48

BioCryst Launches ORLADEYO (Berotralstat) in Ireland

GlobeNewswireNov 18 15:00